!

Official Journal Website: For submissions, editorial correspondence, and author services, use only this official website.

Azerbaijan Medical Journal

Scopus Indexed (2026)

Scopus Indexed Journal & Country Rank

SJR (2026)

Scimago Journal & Country Rank
Aim and Scope

Azerbaijan Medical Journal

The Azerbaijan Medical Journal (AMJ) is a peer-reviewed, open-access monthly publication dedicated to advancing medical science and clinical practice through the dissemination of high-quality, original research. The Journal aims to serve as a global platform for researchers, clinicians, and healthcare professionals to share innovative findings, critical reviews, and evidence-based insights that contribute to the understanding, prevention, diagnosis, and treatment of diseases.

AMJ welcomes submissions across a broad spectrum of medical disciplines, including but not limited to:

  • • Internal Medicine and its subspecialties
  • • Surgery and surgical innovations
  • • Pediatrics and neonatology
  • • Obstetrics, gynecology, and reproductive health
  • • Public health, epidemiology, and global health
  • • Medical education and health policy
  • • Pharmacology and therapeutics
  • • Diagnostic imaging and laboratory medicine
  • • Emerging infectious diseases and pandemic preparedness
  • • Translational and interdisciplinary medical research
  • • Dental health

The Journal particularly encourages contributions from early-career researchers, multidisciplinary teams, and authors from underrepresented regions. All manuscripts undergo rigorous double-blind peer review to ensure scientific integrity, methodological soundness, and relevance to contemporary medical challenges. We invite authors worldwide to submit original articles, review papers, case reports, brief communications, and study protocols that align with the Journal’s mission of promoting excellence, equity, and accessibility in medical scholarship.

Official Submission Process

Manuscripts must be submitted officially through our online system. Please complete the REGISTRATION FORM on our website first to access your Author Dashboard. You may then submit your manuscript for an initial review by our dedicated editorial team to assess its compliance with our journal's policies and scope.

Step-by-Step Submission Process:
  1. 1. Complete registration form
  2. 2. Access your applicant dashboard
  3. 3. Submit a new article
  4. 4. Fill out the submission form. Provide a title and abstract, then upload the required files (PDF, TXT, DOCX, up to 10MB per file, maximum 5 files). The first file is mandatory.
Need Help?

For technical assistance with submission or registration, please contact:

For general editorial questions or policy inquiries:

Latest Articles

Azerbaijan Medical Journal

AMJ-03-10-2024-12302
Bioprinted Vascularized Cardiac Patches Using Patient-Specific Induced Pluripotent Stem Cells for Pediatric Congenital Heart Defect Repair

Author(s): Dr. Emily Roberts

Abstract: Surgical repair of congenital heart defects (CHD) in neonates is limited by donor tissue availability. We bioprinted vascularized cardiac patches using patient-specific iPSC-derived cardiomyocytes, fibroblasts, and endothelial cells embedded in a decellularized myocardial matrix. Sacrificial Pluronic F127 channels enabled spontaneous microvascular network formation perfusable within 7 days. Patches exhibited synchronous contraction, electrophysiological coupling, and calcium handling com...
Read More Azerbaijan Medical Journal • 03-10-2024
AMJ-03-10-2024-12301
Microplastics and Phthalate Co-Exposure Synergistically Disrupt Thyroid Hormone Homeostasis Through Enhanced Gut Barrier Permeability and Systemic Inflammation

Author(s): Dr. Thomas Anderson, Dr. Mei Wong

Abstract: Environmental exposure to microplastics (MPs) and phthalates is ubiquitous, yet their combined endocrine effects are unexplored. We demonstrate that polystyrene microplastics (5 μm) and di(2-ethylhexyl) phthalate (DEHP) synergistically impair thyroid hormone synthesis and metabolism in murine models. Co-exposure disrupted intestinal tight junction proteins (occludin, claudin-1), increasing gut permeability and systemic lipopolysaccharide (LPS) translocation. TLR4-NFκB-mediated inflammation suppr...
Read More Azerbaijan Medical Journal • 03-10-2024
AMJ-05-09-2024-12300
AI-Augmented Digital Pathology Predicts Mismatch Repair Deficiency in Colorectal Cancer with Superior Sensitivity to Immunohistochemistry

Author(s): Dr. Sarah Okafor, Dr. Li Wei, Dr. Ahmed Hassan

Abstract: Lynch syndrome screening relies on immunohistochemistry (IHC) for mismatch repair (MMR) proteins, which suffers from pre-analytic variability. We developed a deep learning algorithm (PathMMR-AI) trained on 5,000 whole-slide images (WSIs) of colorectal cancer (CRC) to predict MMR deficiency (dMMR) directly from hematoxylin-eosin (H&E) stained slides. The model achieved 96.8% sensitivity and 94.2% specificity, outperforming conventional IHC (sensitivity 89.3%) in a prospective validation c...
Read More Azerbaijan Medical Journal • 05-09-2024
AMJ-05-09-2024-12299
A Comparative study to evaluate marginal adaptation of Bioceramic, MTA in vital pulpotomy on primary teeth (an in vitro study)

Author(s): Rama Awad, Abdul Wahab Nourallah

Abstract: Aim: The main goal of this study was to compare the microleakage of MTA and Bioceramic, using Scanning Electron Microscopy in pulpotomized primary molars. Materials and Methods: Study design: 10 extracted primary molars (caries-free or not) were used and randomally distributed among two groups of study (n=5). Pulpotomy was conducted using either MTA or Bioceramic, the teeth were then restored with composite resin. The crowns were resected longitudinally (bucco-lingual direction) into two...
Read More Azerbaijan Medical Journal • 05-09-2024
AMJ-05-09-2024-12298
Base Editing of the PCSK9 Gene in Human Hepatocytes via Lipid Nanoparticle-Delivered Adenine Base Editors: A Non-Viral Approach for Familial Hypercholesterolemia

Author(s): Dr. Alexander Petrov, Dr. Amina Diallo

Abstract: Familial hypercholesterolemia (FH) is characterized by loss-of-function mutations in the LDL receptor pathway. Current therapies require lifelong administration. We report a non-viral gene editing strategy employing adenine base editors (ABE8e) packaged in liver-targeted lipid nanoparticles (LNPs) to precisely disrupt the PCSK9 translational start site in human hepatocytes. In humanized PCSK9 mouse models and primary human hepatocyte spheroids, a single intravenous administration achieve...
Read More Azerbaijan Medical Journal • 05-09-2024
dragon